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ABSTRACT 
 
We investigated the consequences of Fe-limitation on the metabolism of mixed organic 
substrates. The following study presents a stable isotope-assisted metabolomics approach using 
13C-labeled substrates and liquid chromatography-mass spectrometry (LC-MS) to evaluate the 
effects of Fe availability on co-utilization of glucose and benzoate in P. putida KT2440 cells.  
We provide new metabolic insights regarding nutrient dependent carbon metabolism of the 
biotechnologically important Pseudomonas species across three conditions: (1) Fe-replete 
condition, wherein the Fe concentration was within the optimal range for bacterial growth;  
(2) Fe-limited medium, in which no exogenous supply of Fe was provided; and (3), Fe-starved 
condition with ethylene-diamine-tetra-acetic-acid, a strong Fe chelator, in the growth a medium 
to evaluate the effects of very low Fe conditions. Our data revealed that Fe-limitation did not 
have any effect on the biomass growth of the cells but there was an overall increase in substrate 
consumption accompanied by secretion of the pyoverdine siderophore. Under the Fe starvation 
condition, there was a diauxic growth in which the cells first consumed benzoate in the growth 
phase and, upon benzoate depletion, the cells started consuming glucose in the second phase. 
Interestingly, pyoverdine secretion was enhanced during the benzoate consumption phase. These 
results thus demonstrate that the preferential intake of the aromatic substrate as a function of 
decreasing Fe availability was favorable to siderophore production. The present findings provide 
new insights into the metabolic underpinnings of nutrient-dependent carbon metabolism. 
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1. INTRODUCTION 
Due to the role of iron (Fe) as an important cofactor in metabolic enzymes, Fe is a vital 
micronutrient that is essential for carbon metabolism (Andrews et al., 2003; Miransari, 2013). 
However, under aerobic conditions, the bioavailability of Fe is significantly limited. This 
limitation is primarily due to the presence of Fe in forms of lower solubility, Fe oxides and 
hydroxides (Bronstein et al., 2008; Braun and Hantke, 2011). In response to Fe limitation, 
aerobic bacteria deploy strategies to manage carbon metabolism and promote Fe acquisition. One 
notable strategy is the biosynthesis and secretion of high-affinity Fe-chelating specialized 
compounds (or siderophores) and low-affinity Fe-binding organic acids (Andrews et al., 2003). 
The primary siderophore produced by Pseudomonas species are pyoverdines (PVDs), which are 
non-ribosomal peptidic compounds (Peek et al. 2012; Cézard et al. 2015). In addition to the 
peptide chain of variable length, PVDs contain a 2,3-diamino-6,7-dihydroxyquinoline 
chromophore, and a carboxylic acid (or amide) side chain (Wei and Aristilde, 2015). The 
biosynthesis of PVD requires carbon investment from several pathways in the central carbon 
metabolism. The peptide chain is made of amino acids primarily derived from the tricarboxylic 
acid (TCA) cycle. The Fe-binding moieties are synthesized from pentose-phosphate (PP) 
pathway and the TCA cycle (Hider and Kong, 2010) metabolites: the catecholate moiety is 
derived from chorismate, a precursor to aromatic amino acids that is synthesized by combining 
erythrose-4-phosphate, a PP pathway metabolite, and phosphoenolpyruvate (PEP), a metabolite 
upstream of the TCA cycle; the hydroxamate moiety is synthesized from α-ketoglutarate (α-KG), 
a TCA cycle metabolite (Hider and Kong, 2010; Sasnow et al., 2016) (Fig. 1). The side chain 
group, which is composed of dicarboxylic acids (succinic acid and malic acid) or their 
monoamide derivatives, are TCA cycle metabolites (Cézard et al. 2015). The biosynthesis of 
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PVD is a carbon-expensive endeavor that consumes metabolic precursors away from biomass 
growth. Therefore, of special interest is the consequences of Fe-dependent metabolism on 
substrate utilization.  
Here we seek to elucidate the effects of Fe availability on mixed-substrate metabolism in the 
model soil bacterium Pseudomonas putida KT2440. We chose glucose and benzoate for the 
content of our substrate mixture due to their relevance to natural carbon processing, contaminant 
bioremediation, and conversion of organic wastes to biofuels. In addition to being a breakdown 
product of cellulosic materials, glucose is a common carbohydrate in plant secretions (López-
Mondéjar et al., 2016). Benzoate is an important metabolic intermediate in the biodegradation of 
lignin and aromatic contaminants (Michalska et al., 2012; Sudarsan et al., 2014; Sudarsan et al., 
2016). Using 13C tracer experiments, Kukurugya (2017) has elucidated the co-metabolism of 
glucose and benzoate in Fe-replete P. putida cells and quantified the carbon fluxes throughout 
the metabolic network. The initial catabolism of glucose and benzoate follow distinct paths 
before converging into the TCA cycle. Glucose-derived carbons were primarily routed to the 
Entner-Doudoroff (ED) pathway, reverse Embden-Meyerhof-Parnas (EMP) pathway and the PP 
pathway, whereas benzoate-derived carbon was routed almost exclusively to the TCA cycle via 
the ortho-pathway (Kukurugya, 2017) (Fig 1). Previous work on mixed substrate (sugar with 
aromatic compound) metabolism in Pseudomonas species depicted both a lack of substrate 
preference (Cao et al., 2007; Duuren et al., 2012, Sudarsan et al., 2014; Kukurugya, 2017), and a 
diauxic growth profile wherein either glucose or the aromatic substrate was the preferred 
substrate (Basu et al., 2007; Karishma et al., 2016). It remains to be investigated the effect of Fe-
limited metabolism on carbon utilization from substrate mixtures.  
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With respect to effects of Fe availability on the metabolism of a single substrate, a previous 
study of Fe-limited P. putida cells grown on glucose alone reported a seven-fold reduction in the 
biomass growth when compared with Fe-replete cells (Sasnow et al., 2016). Carbon investment 
towards intracellular metabolism was impaired due to significant excretion (up to 50% of the 
carbon uptake) of gluconate, an oxidized glucose metabolite (Sasnow et al., 2016). Despite the 
significant decrease in intracellular carbon assimilation, the glucose-grown Fe-limited cells 
exhibited an equal investment of consumed carbon towards biomass growth and the PVD 
siderophore secretion (Sasnow et al., 2016). Furthermore, compared to P. putida cells grown 
solely on glucose, it was reported that cells grown on benzyl alcohol (an aromatic substrate) 
alone had more than 2-fold increase in PVD secretion (Joshi et al., 2014). This enhanced PVD 
secretion was proposed to be due to the high Fe demand for Fe-depending oxygenases, which are 
required to catalyze the aromatic substrate (Joshi et al., 2014). The consequences of Fe-limitation 
on mixed substrate metabolism and PVD production have not been elucidated.  
Using a stable isotope-assisted metabolomics approach with liquid chromatography-mass 
spectrometry (LC-MS), we investigate the following four hypotheses regarding the effects of Fe 
availability on co-utilization of glucose and benzoate in P. putida KT2440 cells.: (1) the total 
carbon uptake from both substrates, and the biomass growth will be significantly decreased in 
Fe-limited cells compared to Fe-replete cells; (2) carbon-investment from glucose will be 
compromised due to rerouted glucose catabolism to gluconate secretion in Fe-limited cells; (3) 
catabolism of benzoate-derived carbons will be favored in Fe-limited cells due to their direct 
investment into the TCA cycle metabolite precursors to enhance PVD biosynthesis; (4) the 
carbon fluxes through the metabolic network will be regulated to accommodate selective 
substrate utilization from the mixture. We provide new metabolic insights regarding nutrient 
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dependent carbon metabolism of the biotechnologically important Pseudomonas species across 
three conditions: (1) Fe-replete growth medium, wherein the Fe concentration in growth medium 
was within the optimal range for bacterial growth (Vasil et al., 1999; Kim et al., 2009); (2) Fe-
limited growth, in which no exogenous supply of Fe was provided; and (3) Fe-starved condition 
with ethylene-diamine-tetra-acetic-acid (EDTA) in the growth medium, a strong Fe chelator to 
evaluate the effects of very low Fe conditions (Kim et al., 2009). With these findings, we 
contribute to an emerging framework in understanding nutrient limitation, carbon metabolism 
and their co-dependence. 
 
Fig.1: The metabolic routes through the Entner-Doudroff (ED) pathway, the pentose phosphate pathway 
(PPP), and the tricarboxylic acid (TCA) cycle are shown in black, the metabolites that are involved in 
siderophore biosynthesis are shown in red and the location of Fe-containing enzymes are shown in blue. 
Gluconate, Glucn; 2-ketogluconate, 2-keto-glucn; 6-phospho-gluconate, 6-PG; glucose-6-phosphate, G6P; 
fructose-6-phosphate, F6P; fructose-1,6-biphosphate, FBP; dihydroxyacetone-phosphate, DHAP; 
glyceraldehyde-3-phosphate, GAP; 3-phosphoglycerate, 3-PG; phosphoenolpyruvate, PEP; acetyl coenzyme 
A, A-coA; carbon dioxide, CO2 (Figure courtesy of Dr. Ludmilla Aristilde, 2017). 
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2. MATERIALS AND METHODS 
2.1 Culturing Conditions 
Pseudomonas putida KT2440 was acquired from ATCC (American Type Culture Collection, 
Manassas, VA) as freeze-dried cultures and were plated on agar-solidified Luri-Bertani (LB) 
medium and stored at 4°C until use. The cells were re-suspended in LB medium as liquid 
cultures after selection of individual colonies from the plates. Liquid culturing was conducted in 
a G24 incubator shaker (New Brunswick Scientific, Edison, NJ) shaken at 220 rpm at 30°C in 
250-mL baffled flasks. The volume of the suspended cells did not exceed 25-mL (i.e., one-tenth 
of total flask volume); the flasks were covered with sponge caps to enable gas exchange and 
prevent contamination.  
The growth medium, which was filter-sterilized and pH-adjusted (pH 7.0) contained the 
following salts in Milli-Q water: 18.7 mM NH4Cl, 0.81 mM MgSO4, 34 µM CaCl2•2H2O, 89.4 
mM K2HPO4, 56.4 mM NaH2PO4•H2O, 8.6 mM NaCl and trace metals as 1.9 µM H3BO3, 0.86 
µM CuSO4•5H2O, 7.7 µM ZnSO4•7H2O, 0.75 µM MnSO4•H2O, 0.26 µM NiCl2•6H2O, 0.31 µM 
Na2MoO4•2H2O. The total carbon-equivalent substrate concentration of 100 mM C was added as 
50 mM C glucose and 50 mM C sodium benzoate. No exogenous supply of Fe was provided. 
However, the background dissolved Fe content was determined to be 650 nM by inductively 
coupled plasma atomic emission spectroscopy (ICP-AES, Spectro Analytical). In order to ensure 
nutrient limitation, 0.09 mM of a strong metal chelator disodium-EDTA was added following the 
addition of the organic substrates. The concentration of EDTA to be added, was determined by 
ensuring that bioavailable equilibrium Fe concentration was within the nutrient limited range, 
and was obtained using Visual MINTEQ (version 3.1) (Vasil et al., 1999; Kim et al., 2009). 
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Hence, the two conditions of nutrient limitation obtained were without (Fe-limited) or with (Fe-
starved) EDTA. 
For the growth experiments with each Fe condition, the cells (three biological replicates) 
were transferred twice in the growth medium (containing major and minor salts, carbon source, 
without or with EDTA) to ensure the cells were acclimated. Biomass growth was monitored by 
measuring the optical density at 600 nm (OD600) using an Agilent Cary UV-visible 
spectrophotometer (Santa Clara, California). An exponential growth rate (h-1) was determined 
via regression analysis. Measurement of cell dry weight in grams (gCDW) as a function of 
exponential OD600 was obtained following lyophilization of sample aliquots (1.5-mL) using a 
Labconco (Kansas City, MO, USA) Freeze-Dryer System. A conversion factor of 0.586±0.2 
gCDW L
-1 per OD600 and 0.6±0.2 gCDW L
-1 per OD600 was determined for the Fe-limited and Fe-
starved cells, respectively. 
 
2.2 Substrate Consumption and intracellular metabolite labeling 
To quantify the rate of consumption of substrate, 0.5-mL of samples (three biological replicates) 
were harvested during the exponential growth of the cells and filter-centrifuged (Sigma Aldrich 
Spin-X 0.22 µm filters) at 9391g for 5 mins at 4°C (Centrifuge 5423 R, Eppendorf, Hauppauge, 
NY). The supernatants were stored at 4°C until analysis for simultaneous quantification of 
glucose and benzoate by 1H nuclear magnetic resonance (NMR). In preparation for analysis, 
200-µL of filtered sample was mixed with 60-µL of 100% D2O, 50-µL of 6 mM 2,2-dimethyl-2-
silapentane-5-sulfonate (DSS) as an internal standard, 240-µL of 100 mM sodium bicarbonate as 
a pH control and 50-µL of 10 mM sodium-azide as an antimicrobial agent (Kukurugya, 2017). 
The 1H NMR measurements were performed using a Varian Unity INOVA 600-MHz NMR 
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spectrometer at 25°C with a relaxation delay of 5s, recording of 16 scans per sample and a 
receiver gain of 32 dB. The consumption rates (mmol gCDW
-1 h-1) of glucose and benzoate by the 
exponentially-growing cells were determined via regression analysis.  
Intracellular incorporation of assimilated substrates was monitored by determining 
metabolite labeling patterns following growth on two different labeling schemes. [U-13C6]-
glucose and unlabeled benzoate; [1,5,6-13C6]-glucose and unlabeled benzoate (labeled substrates 
were purchased from Cambridge Isotopes (Tewskbury, MA, USA) or Omicron Biochemicals 
(South Bend, IN, USA)) cultures (three biological replicates) were grown twice in minimal 
media containing the labeled substrate combination specified above. The isotopic labelling 
patterns were retrieved using the Metabolomics Analysis and Visualization Engine (MAVEN) 
software package (Clasquin et al., 2012) and the 13C-labelled fractions were corrected for natural 
13C abundance. To determine that the cells were at metabolic pseudo-steady state, both labeling 
patterns and the metabolite levels were determined at two time points during exponential phase.  
 
2.3 Extracellular Metabolite Excretion  
For quantitation of extracellular metabolic excretion, samples (three biological replicates) were 
harvested at several time points throughout the exponential growth phase and 50-µL of filtered 
supernatant was diluted 1:10 or 1:100 with LC-MS grade water (Fisher Scientific, Pittsburgh, 
PA) before analysis via LC-MS (see section 4). The excretion rates (µmol gCDW
-1 h-1) for 
metabolites of interest (gluconate, a-KG, succinate, pyruvate, citrate, oxaloacetate, glutamate, 
fructose 6-phosphate, glucose 6-phosphate, malate, dihydroxyacetone phosphate, 
phosphoenolpyruvate) were computed via regression analysis.  
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2.4 Metabolomics Analysis via LC-MS 
Samples were analyzed by reversed-phase ion-pairing LC via ultra-high performance LC 
(UHPLC; Thermo Scientific DionexUltiMate 3000) coupled to high-resolution accurate-mass 
mass spectrometer (MS; Thermo Scientific Q Exactive) with electrospray ionization operated in 
full-scan negative mode (m/z range 70-900). Mobile phases for the LC-MS consisted of solvents 
A and B: Solvent A was composed of 97:3 (v/v) LC-MS grade H2O:methanol with 15 mM acetic 
acid and 10 mM tributylamine; Solvent B was pure methanol. The flow rate was 180 µL min-1 
for the duration of a single sample run (25 min). The solvent gradient with respect to solvent A 
was: 0 min, 100%; 2.5 min, 100%; 5 min, 80%; 7.5 min, 80%; 10 min, 45%; 12 min, 45%; 14 
min, 5%; 17 min, 5%; 18 min, 0%; 25 min, 0% (Kukurugya, 2017). An injection sample of 10-
µL was used and the column (Acquity UPLC Water 1.7µm particle size) temperature was set to 
25°C (Kukurugya, 2017; Sasnow et al, 2016). The metabolites of interest were gluconate, 2-keto 
gluconate, glucose-6-phosphate, fructose-6-phosphate, fructose-1,6-bisphosphate, 
dihydroxyacetone phosphate, Glyceraldehyde-3-phosphate, 3-phosphoglycerate, 
phosphoenolpyruvate, pyruvate, citrate, α-ketoglutarate, succinate, fumarate, malate, acetyl 
coenzyme-A, sedoheptulose-7-phosphate, ribose-5-phosphate, ribulose-5-phosphate, erythrose-4-
phosphate, glutamine and aspartate. Aspartate was taken as a surrogate for oxaloacetate (OAA) 
owing to the direct synthesis of aspartate from OAA (Kukurugya, 2017; Sasnow et al. 2016; 
Amador-Noguez et al. 2010).  
 
2.5 Pyoverdine Quantitation 
The extracellular amount of secreted PVD siderophore was determined in pH-adjusted (pH 7) 
bacterial supernatants (three biological replicates) as done previously using absorbance (400 nm) 
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(Ferret et al. 2014; Sasnow et al. 2016). A PVD standard (Sigma Aldrich) isolated from a P. 
flourescens strain was used for quantitation. It was verified via LC-MS that both the standard and 
the PVD secreted by the strain under study (KT2440) possessed the same dihydroxyquinoline-
type chromophore (Wei and Aristilde, 2015). The PVD excretion rate (µmol gCDW
-1 h-1) of the 
exponentially-growing liquid cultures was calculated via regression analysis.  
 
2.6 Metabolic Flux Analysis 
The software suite 13CFLUX2 package (http://www.13cflux.net) was used to perform a 
metabolic flux analysis (MFA) for quantitative modelling of fluxes through central carbon 
metabolism, and biosynthetic fluxes for biomass growth and PVD biosynthesis. The MFA was 
constrained using the following experimental data (averaged values ± standard deviation): 
substrate uptake rate, metabolite excretion rates, PVD secretion rate, labeling patterns of 
metabolites from the long-term labeling experiments with [1,5,6-13C3]-glucose and unlabeled 
benzoate, and calculated effluxes toward biomass production. Substrate consumption rates and 
metabolite excretion rates were measured using NMR analysis and LC-MS analysis, 
respectively, as described above. Using the biomass growth rates determined experimentally (as 
described above) and published biomass composition of P. putida KT2440 (Van Durren et al., 
2013), the effluxes towards biomass production from glycolytic, PP and TCA cycle metabolites 
were calculated (Nikel et al., 2015; Sasnow et al., 2016; Kukurugya, 2017). The software was 
applied to set up the modeled metabolic network of reactions. Initial flux values at the start of the 
optimization procedure were set based on published values (Nikel et al., 2015; Sasnow et al., 
2016; Kukurugya, 2017). The model-estimated labeling patterns from the modeling of the 
stoichiometric reaction network were optimized on the measured labeling pattern.  
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3. RESULTS AND DISCUSSION 
3.1 Growth phenotype and substrate consumption 
We determined the exponential growth rates and the carbon uptake rate in P. putida KT 2440 
cells grown on 100 mM C of 1:1 glucose:benzoate mixture under both Fe-limited and Fe-starved 
conditions. A previous study of Fe-replete P. putida KT2440 grown on the same carbon-
equivalent glucose:benzoate mixture reported a growth rate of 0.93±0.1h-1 (Kukurugya, 2017). 
Remarkably, the growth rate obtained for Fe-limited and Fe-starved cells was found to be in 
close agreement with the Fe-replete cells, at 0.89±0.18h-1 and 0.89±0.11 h-1, respectively (Fig 3). 
This similarity in growth rates implied a coping mechanism of the P. putida cells in response to 
Fe-limitation towards maintenance of biomass growth from the mixed-substrate growth medium. 
By contrast, for P. putida KT2440 cells grown solely on glucose alone, there was a seven-fold 
reduction in growth rate, from 0.60±0.04 h-1 for Fe-replete cells to 0.08±0.02 h-1 in Fe-limited 
cells (Sasnow et al., 2016). We note here that mixed substrate-grown cells under Fe-starvation 
exhibited a clear diauxic growth wherein the second growth phase (0.26±0.08 h-1) was a four-
fold less than the growth rate of 0.89±0.11 h-1 recorded for the first phase (Fig 2 and Fig 3). 
 To evaluate the influence of substrate consumption on the growth phenotypes, we obtained 
the extracellular depletion of glucose and benzoate (Fig 4). For Fe-replete cells grown on the 
mixed substrate, the carbon-equivalent consumption rate of glucose and benzoate was reported to 
be 19.8±4.4 mmol C gCDW
-1 h-1 and 27.2±8.1 mmol C gCDW
-1 h-1, respectively (Kukurugya, 
2017). Therefore, the total Fe-replete carbon consumption rate of the substrate mixture was 
47.0±11.1 mmol C gCDW-1 h-1. Under Fe-limitation, we obtained a total consumption rate of 
70.1±17.18 mmol C gCDW-1 h-1 (Fig 4). In accordance with the aforementioned diauxic growth 
of the Fe-starved cells, the trend of the carbon consumption was divided across two phases. In 
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the first phase, the benzoate consumption rate was measured to be 52.2±11.4 mmol C gCDW
-1 h-1 
but the glucose consumption rate was minimal at 2.0±0.9 mmol C gCDW
-1 h-1 (Fig 4). In the 
second phase, the glucose consumption, which began upon near-complete benzoate depletion, 
was determined to be 23.8±7.0 mmol C gCDW
-1 h-1 (Fig 4). 
Therefore, these data indicated that the benzoate consumption rate was greater than the 
glucose consumption rate by, on average, 57.2% in Fe-limited cells and, during the first growth 
phase, by 96% in Fe-starved cells (Fig 4) whereas an equal rate of benzoate and glucose 
consumption was reported for Fe-replete cells. Thus, these findings implied increased preference 
towards an aromatic substance as a function of decreased Fe availability. In order to confirm the 
preferential substrate consumption and to understand Fe-dependent carbon metabolism of mixed 
substrate, we investigated the investment of assimilated glucose and benzoate into the 
intracellular metabolites into the different central metabolic pathways: the ED pathway, reverse 
EMP pathway, PP pathway and the TCA cycle.  
 
Fig 2: Growth curves for P. putida KT2440 cells grown on Fe-replete (Kukurugya, 2017), Fe-limited and 
Fe-starved glucose-benzoate mixture. 
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Fig 3: Growth rates (h-1) for P. putida KT2440 cells grown on glucose-benzoate mixture during Fe-
replete (Kukurugya, 2017), Fe-limited and Fe-starved conditions. 
 
 
        
 
 Fig 4: Consumption of glucose and benzoate for P. putida KT2440 cells grown on Fe-replete 
(Kukurugya, 2017), Fe-limited and Fe-starved glucose-benzoate mixture. 
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Fig 5: Carbon equivalent consumption rates (mmol C gCDW-1 h-1) for P. putida KT2440 cells grown on 
Fe-replete (Kukurugya, 2017), Fe-limited and Fe-starved glucose-benzoate mixture. 
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metabolites at two different times (OD600 of 0.4 and 0.8) (Fig. S3, Fig. S4, and Fig. S5). The data 
obtained under the Fe-replete conditions for the same labeling schemes revealed that the cells 
partitioned carbons derived from benzoate to the TCA cycle and carbons derived from glucose to 
the ED pathway, reverse EMP pathway and the PP pathway (Kukurugya, 2017). We compared 
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starved conditions (Fig. 8, Fig. 9, and Fig. 10). First, we monitored the labeling patterns of 
metabolites into the ED and reverse EMP pathways (Fig. 6 and Fig. 7). In accordance with 
uptake and initial catabolism of the labeled glucose, we found that Glucn and 6PG was almost 
completely fully 13C-labeled (99.9 ± 0.4%, 95.5 ± 1.2% and 99.9 ± 0.0% for Fe-replete, Fe-
limited and Fe-starved cells, respectively) (Fig 7). As the keto-pathway is absent in 
Pseudomonas putida KT2440, benzoate-derived carbons can enter the TCA cycle through 
succinate and acetyl-coA, via the ortho-pathway (Fig. 8). Through the established flow of the 
TCA cycle, carbons from succinate can be routed to malate and OAA and be subsequently 
introduced to the EMP pathway via the malate shunt to pyruvate and two anaplerotic reactions, 
OAA to pyruvate and OAA to PEP (Fig. 8). Pyruvate can in turn be converted to acetyl co-A 
directly upstream of the TCA cycle. In the direction of gluconeogenesis, pyruvate may be 
converted to 3PG, which can then be converted to GAP and DHAP (Fig. 6). The appreciable 
triply 13C-labeled fraction of FBP (18.9 ± 0.6% and 17.3 ± 1.1 %, correspondingly for Fe-limited 
and Fe-starved cells), F6P (24.2 ± 2.7 % and 25.4 ± 4.9 % for Fe-limited and Fe-starved 
conditions, respectively) and G6P (9.6 ± 1.3% and 10.1 ± 0.8% ), indicated a small 
gluconeogenic flux of benzoate-derived carbons in the upper portion of the reverse EMP (Fig. 7). 
This increase in the triply 13C-labeled fraction, which was consistent with enhanced contribution 
of benzoate carbons towards the ED and reverse EMP pathways.  However, DHAP had a greater 
fraction of non-labeled carbons: 6.7 ± 0.1%, 31.7 ± 0.4% and 32.2 ± 0.2% in Fe-replete, Fe-
limited and Fe-starved cells, respectively (Fig. 7). Thus, the DHAP labeling also indicated that 
incorporation of benzoate-derived carbons through gluconeogenic flux was greater in the Fe-
limited and Fe-starved cells than in Fe-replete cells.  With regards to the PP pathway, the 
presence of doubly and triply 13C labeled R5P and X5P indicated that carbon from benzoate was 
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present (Fig. 10).  In addition, absence of non-labeled carbon in 6-PG across all Fe-conditions 
confirmed that the non-labeled carbon was introduced to the PP pathway through non-oxidative 
branch, i.e., via GAP and F6P. 
 
 
 
Fig 6: Schematic representation of 13C-labeled metabolites in ED and reverse EMP when grown on [U-13C6]-
glucose and unlabeled benzoate (Kukurugya, 2017). Metabolite abbreviations are the same as in Fig 1. 
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Fig 7: Labeling of the ED and reverse EMP pathway metabolites in pseudo-steady state at optical density 
(OD600) 0.4 in Fe-limited and Fe-starved cells; 0.5 in Fe-replete cells (Kukurugya, 2017) when grown on [U-
13C6]-glucose and unlabeled benzoate. Metabolite abbreviations are the same as in Fig 1. 
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The 13C-labeling pattern of metabolites in the TCA cycle were in accordance with the 
canonical routing of carbon through the pathways mentioned above (Fig. 8). Acetyl-CoA can be 
either non-labeled or doubly 13C-labeled, owing to the decarboxylation of unlabeled or triply 13C-
labeled pyruvate, respectively. Non-labelled acetyl-coA can also be generated from carbon entry 
through the ortho-pathway of benzoate breakdown. Aspartate was taken as surrogate to OAA, 
and it was observed that in the Fe-replete conditions, OAA was almost 59.3±0.1% non-labeled 
(Kukurugya, 2017). However, in the Fe-stressed conditions the non-labeled fractions increased 
with the extent of Fe-limitation accordingly. In the Fe-limited cells, OAA was 91.2±0.4% non-
labeled while in the Fe-starved condition, it was 95.8±0.4% non-labeled (Fig 9), therefore, 
confirming our hypothesis of an increase in aromatic substrate incorporation, with the increase in 
the extent of Fe-limitation. This trend was consistent among all the metabolites in the TCA 
cycle, namely, succinate, malate, fumarate, pyruvate, a-kg and PEP, suggesting the incorporation 
of carbon from the unlabeled aromatic substrate. Citrate was majorly non-labeled due to the 
combination of mostly non-labeled acetyl-coA with mostly non-labelled OAA. Fully labeled 
fractions of acetyl-coA and glyoxylate combine to yield 27.6±0.8% and 27.8±1.0% fully labeled 
malate in the Fe-limited and Fe-starved conditions, respectively.  
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Fig.8: Schematic representation of 13C-labeled metabolites in central carbon metabolism when grown on [U-
13C6]-glucose and unlabeled benzoate in reverse EMP pathway and TCA cycle (Kukurugya, 2017). 
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Fig 9: Labeling of the TCA cycle metabolites in pseudo-steady state at optical density (OD600) 0.4 in Fe-
limited and Fe-starved cells; 0.5 Fe-replete cells (Kukurugya, 2017) when grown on [U-13C6]-glucose and 
unlabeled benzoate. Metabolite abbreviations are the same as in Fig 1. 
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Fig 10: Labeling of the PP pathway metabolites in pseudo-steady state at optical density (OD600) 0.4 in Fe-
limited and Fe-starved cells; 0.5 Fe-replete cells (Kukurugya, 2017) when grown on [U-13C6]-glucose and 
unlabeled benzoate. Metabolite abbreviations are the same as in Fig 1. 
 
 
In summary, glucose-derived carbons mainly populated the ED and reverse EMP pathways 
across all conditions, with a minor contribution of benzoate-derived carbons in G6P, DHAP, 
FBP and F6P for the Fe-limited and Fe-starved conditions. The TCA cycle was mainly 
dominated by benzoate-derived carbons with a minimal input of glucose-derived carbon. Citrate, 
a-KG, PEP, fumarate and OAA displayed a 30-35% increase in the non-labeled fraction of 
carbon in the Fe-stressed conditions in comparison with the Fe-replete conditions. Further 
analysis into the selective partitioning of the metabolite labelling, as required for the metabolic 
flux analysis (MFA) was obtained by performing additional long-term isotopic enrichment of 
intracellular metabolites on [1,5,6-13C3]-glucose and unlabeled benzoate. 
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3.3 Metabolic Network Structure 
We elucidated the selective partitioning of both glucose and benzoate-derived carbons in specific 
pathways in the metabolic network. We performed long-term isotopic enrichment of intracellular 
metabolites by growing cells on [1,5,6-13C3]-glucose and unlabeled benzoate under Fe-limited 
and Fe-starved conditions. To ascertain that the isotopic enrichment was at steady-state, we 
compared the 13C-labeling patterns of metabolites extracted from cells at two different times 
(OD600 of 0.4 and 0.8) during the exponential growth phase (Fig. 12, 13, 14, 16, 17, 18, 20, 21 
and 22). These results were similar to the metabolic network structure elucidated for Fe-replete 
P. putida cells grown on a mixed substrate of glucose and benzoate (Kukurugya, 2017).  
We began by establishing the network of carbon flow for initial glucose catabolism, the ED 
pathway and the reverse EMP pathway (Fig. 11). We found that the oxidation of triply 13C-
labeled glucose yielded nearly completely triply 13C-labeled gluconate in the periplasm of Fe-
limited (93.9±6.8%) cells and in the first (98.9±0.2%) and second (99.9±0.1%) growth phases of 
Fe-starved cells (Fig. 12, Fig 13, Fig. 14). Accordingly, the phosphorylated metabolites in 
glucose catabolism, G6P and 6-PG, were also predominantly triply 13C-labeled, 53.8±8.0% and 
86.4±4.1%, respectively in the Fe-limited growth medium; 63.3±4.2% and 76.4±2.1%, 
respectively in the first phase of Fe-starved growth and finally, 62.3±1.0 and 78.9±0.1, 
respectively in the second phase of Fe-starved growth (Fig. 12, Fig. 13, Fig. 14). The precursors 
of 6-PG are both gluconate and G6P and therefore, the higher enrichment in triply 13C-labeled 6-
PG compared to G6P inferred greater flux of gluconate towards the biosynthesis of 6-PG (Fig. 
12, Fig. 13 and Fig. 14). Moving further down the ED pathway, triply 13C-labeled 6-PG splits 
into singly 13C-labeled pyruvate (38.7±4.0%, 11.6±2% and 36.7±4% in Fe-limited, Phase 1 Fe-
starved and Phase 2 Fe-starved cells, respectively) and doubly 13C-labeled GAP (91.7±0.0%, 
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64.6±4.6% and 94.9±4% in Fe-limited, Phase 1 Fe-starved and Phase 2 Fe-starved cells, 
respectively) (Fig. 12, Fig. 13, and Fig. 14). DHAP, an isomer of GAP exhibited the similar 
labeling trend (Fig. 12, 13 and 14). The presence of doubly 13C-labeled pyruvate under the Fe-
limitation (42.4±4%), and Fe-starvation (4.4±0.1% for phase 1 and 23.7±4.3% for phase 2) 
underlined the contribution of both the ED pathway and the metabolites downstream of GAP to 
form pyruvate (Fig. 12, 13 and 14). Doubly 13C-labeled forms of 3-PG and PEP were, 
respectively 45.8±6.3% and 33.7±3.6% in Fe-limited cells and 21.7±5.0% and 8.7±1.0% in 
phase 1 of Fe-starved cells (Fig. 12 and Fig. 13). However, during the second phase of growth, 
there was a significant increase in the doubly labeled fractions of 3-PG and PEP (91.5±5% and 
86.1±0.0%, respectively) (Fig. 14), thereby implying a greater incorporation of glucose-derived 
carbons. The decrease in the non-labeled fraction of pyruvate (39.4±0.8%) was accompanied by 
an increase in the doubly 13C-labeled fraction (23.7±4.3%) (Fig. 14). Therefore, the data 
confirmed that non-labeled benzoate-derived carbons were incorporated into 3-PG, PEP and 
pyruvate under Fe-limitation and during the first growth phase under Fe-starvation whereas 
glucose-derived carbons were primarily populated by 3-PG, PEP and pyruvate in the second 
growth phase of Fe-starved cells.  
The fraction of non-labeled DHAP was significantly low in the second phase of Fe-starved 
growth (3.8±2.0%) and in the Fe-limited (8.5±0.0%) condition. However, during the growth on 
the first phase of Fe-starvation, non-labeled DHAP was 35.2±5.0%, indicating significant 
assimilation of benzoate-derived carbons even upstream of 3-PG. In agreement with the 
metabolic framework developed for the Fe-replete cells (Kukurugya, 2017), we found that 
through the reverse EMP pathway, the ED pathway-generated doubly 13C-labeled GAP combines 
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with its isomer DHAP to form quadruply 13C-labeled FBP, which then dephosphorylates to F6P 
(Fig.11).  
Proceeding further down the reverse EMP pathway, we obtained quadruply 13C-labeled 
forms of both FBP and F6P during growth on Fe-limited medium (respectively, 63.4 ± 5.5% and 
63.1 ± 3.0%), phase 1 (respectively, 36.2± 7.0% and 20.8 ± 4.0%) and phase 2 (respectively, 
81.3±6.9% and 47.4±3.7%) of the Fe starved condition (Fig. 12, 13 and 14). The formation of 
G6P can result either from the isomerization of F6P or from the phosphorylation of glucose 
wherein the first reaction would generate quadruply 13C-labeled G6P and the second reaction 
would provide only triply 13C-labeled G6P (Fig. 11). We found that quadruply 13C-labeled 
fraction of G6P in cells grown under Fe-limitation (39.5.4±8.5%) and in the second phase of Fe-
starvation (24.2±0.1%) was higher than quadruply 13C-labeled fraction of G6P in the first phase 
of Fe-starved cells (10.1±2.9%). This implied a reduced recycling flux of assimilated glucose 
through the first growth phase of Fe-starved cells. 
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Fig. 11: Schematic representation of 13C-labeled metabolites in central carbon metabolism when grown on 
[1,5,6-13C3]-glucose and unlabeled benzoate in ED and reverse EMP pathways. Metabolite abbreviations are 
the same as in Fig 1 (Figure courtesy of Dr. Ludmilla Aristilde, 2017). 
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Fig. 12: The isotopic labeling fractions, with standard deviations, for intracellular metabolites in the ED and 
EMP pathways when grown on [1,5,6-13C3]-glucose and unlabeled benzoate under Fe-limitation at O.D600 0.4 
and 0.8. Metabolite abbreviations are the same as in Fig 1. 
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Fig. 13: The isotopic labeling fractions, with standard deviations, for intracellular metabolites in the ED and 
EMP pathways when grown on [1,5,6-13C3]-glucose and unlabeled benzoate during the first phase of growth 
under Fe-starvation at O.D600 0.4 and 0.8. Metabolite abbreviations are the same as in Fig 1. 
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Fig. 14: The isotopic labeling fractions, with standard deviations, for intracellular metabolites in the ED and 
EMP pathways when grown on [1,5,6-13C3]-glucose and unlabeled benzoate during second phase of growth 
under Fe-starvation at O.D600 0.4 and 0.8. Metabolite abbreviations are the same as in Fig 1. 
 
Pertaining to the PP pathway, the labeling patterns of Xu5P and R5P indicated the 
participation of both the oxidative and non-oxidative routes of the PP pathway as reported in Fe-
replete cells (Fig. 15). Through the oxidative pathway, a decarboxylation reaction generates 
doubly 13C-labeled pentose-phosphate metabolites from triply 13C-labeled 6-PG (Fig. 15). During 
growth on the Fe-limited condition, we measured the doubly 13C-labeled forms of R5P and Xu5P 
at, correspondingly, 42.0 ± 0.0% and 38.2±5.4%; the corresponding values during growth on the 
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Fe-starvation were 55.7 ± 0.2% and 55.8± 0.3%, respectively for the first phase, and 65.6±6.2% 
and 63.5±3.7% for the second phase (Fig. 16, 17 and 18). Given the high fraction of 6-PG in 
triply 13C-labeled forms, the relatively low fraction of doubly 13C-labeled R5P and Xu5P 
indicated that the oxidative PP pathway was not the major biosynthetic route for these PP 
metabolites under both growth conditions, as previously reported for P. putida KT2440 cells 
(Sasnow et al., 2016; Kukurugya, 2017). Through the non-oxidative pathway, the labeling 
patterns of F6P and GAP mentioned above combine through a series of reactions to generate 
eventually quadruply 13C-labeled Xu5P and R5P. However, the 13C-labeling pattern of S7P, 
another intermediate in the PP pathway, indicated an alternate routing of carbons within the non-
oxidative PP pathway for each condition (Fig. 15). There are two ways of generating S7P: (1) via 
the transketolase reaction wherein the first two carbons from Xu5P combines with R5P and (2) 
via the transaldolase reaction where the first three carbons from F6P combines with E4P. The 
transketolase reaction would therefore primarily yield quadruply and sextuply 13C-labeled forms 
of S7P whereas the transaldolase reaction would yield mostly quadruply 13C-labeled S7P and 
some quintuply 13C-labeled S7P (as the backward flux of the transaldolase reaction would 
produce triply 13C-labeled E4P that would yield the quintuply 13C-labeled S7P when combined 
with F6P in the forward flux (Fig. 15). When fed on the Fe-starved medium, the cells generated 
two main labeled forms of S7P: primarily quadruply 13C-labeled (26.5±6.9% and 40.0±1.8% for 
the first and second phase, respectively) and doubly 13C-labeled (36.2±1.8% and 28.6±0.4% for 
the first and second phase, correspondingly) (Fig. 17 and 18). On the other hand, the cells fed on 
the Fe-limited mixture had primarily quadruply 13C-labeled S7P (49.1 ± 3.5%) and sextuply 13C-
labeled S7P (17.4 ± 1.5%) (Fig. 16). Therefore, S7P was primarily made from the transaldolase 
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reaction during Fe-starved growth but primarily from the transketolase reaction downstream of 
the oxidative PP pathway during Fe-limited growth.  
 
Fig. 15: Schematic representation of 13C-labeled metabolites in PP pathway when grown on [1,5,6-13C3]-
glucose and unlabeled benzoate. Metabolite abbreviations are the same as in Fig 1.
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Fig. 16: The isotopic labeling fractions, with standard deviations, for six intracellular metabolites in the PP 
pathway when grown on [1,5,6-13C3]-glucose and unlabeled benzoate under Fe-limitation at O.D600 0.4 and 
0.8. Metabolite abbreviations are the same as in Fig 1. 
 
 
Fig. 17: The isotopic labeling fractions, with standard deviations, for six intracellular metabolites in the PP 
pathway when grown on [1,5,6-13C3]-glucose and unlabeled benzoate during first phase of Fe-starvation at 
O.D600 0.4 and 0.8. Metabolite abbreviations are the same as in Fig 1. 
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Fig. 18: The isotopic labeling fractions, with standard deviations, for six intracellular metabolites in the PP 
pathway when grown on [1,5,6-13C3]-glucose and unlabeled benzoate during second phase of Fe-starvation at 
O.D600 0.4 and 0.8. Metabolite abbreviations are the same as in Fig 1. 
 
We then proceeded to monitor the assimilation of carbons through the TCA cycle. During 
the first phase of Fe-starved growth, the non-labeled fraction of pyruvate (84.5 ± 8.1%) and PEP 
(89.1 ± 1.9%) was significantly higher than the non-labeled fractions of pyruvate and PEP in Fe-
limited (12.1±3.1% and 59.3±4.4%, respectively) and second phase of Fe-starved growth (39.5 ± 
8.8% and 9.4 ± 0.0%, respectively) (Fig. 20, 21 and 22). This indicated a higher gluconeogenic 
flux from TCA cycle metabolites in the first phase of Fe-starved growth. During the second 
phase of Fe-starved growth, the 13C-labeling patterns of metabolites were consistent with the 
canonical routing of carbons through the TCA cycle (Fig. 19). The anapleurotic reactions 
through the carboxylation of pyruvate and PEP (incorporating either non-labeled or singly 13C-
labeled carbon dioxide) would produce the same labeling patterns as described above for PEP 
and pyruvate without or with one extra 13C-labeled carbon (Fig. 20, 21 and 22). Accordingly, 
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OAA (through aspartate) was determined to be 48.8 ± 9.0% non-labeled, 24.7 ± 3.0% singly, 
21.6 ± 2.1% doubly, 4.3 ± 0.0% triply (Fig. 5). Decarboxylation of pyruvate produces non-
labeled acetyl-CoA (from both non-labeled and singly and 13C-labeled pyruvate) and doubly 13C-
labeled acetyl-CoA (from doubly 13C-labeled pyruvate) (Fig. 19). The labeling pattern of citrate 
(38.1 ± 0.5% non-labeled, 22.7 ± 0.6% singly, 25.4 ± 0.2% doubly, 9.0± 0.5% triply, and 4.0 ± 
0.4% quadruply 13C-labeled) was consistent with the combination of acetyl-CoA with OAA (Fig. 
5). Subsequent decarboxylation of citrate produced α-KG (48.75 ± 3.8 % non-labeled, 20.9 ± 
0.0% singly, 21.6 ± 2.1% doubly, 6.0 ± 0.0% triply, and 2.2 ± 0.0% quadruply 13C-labeled) (Fig. 
22). The labeling pattern of fumarate (80.4 ± 2.2% non-labeled, 11.1 ± 0.0% singly, 8.0 ± 0.2% 
doubly) was consistent with the occurrence of another decarboxylation step between α-KG to 
produce succinate, the direct precursor to fumarate (Fig. 22). In Fe-limited and phase one Fe-
starved cells, the influx of carbons from benzoate catabolism via the ortho pathway was greater. 
We take note that the similarity between labeling patterns of citrate and OAA indicated that the 
acetyl moiety in acetyl-CoA originated exclusively from benzoate (Fig. 19). In the Fe-limited 
cells, Citrate (80.6± 0.4% non-labeled, 11.9 ± 0.6% singly, and 5.6 ± 0.2% doubly 13C-labeled) 
was produced from combining the non-labeled acetyl moiety with OAA (83.9 ± 0.3% non-
labeled, 9.3 ± 0.4% singly, and 5.3 ± 0.3% doubly 13C-labeled) (Fig. 5). The continuing TCA 
cycle metabolites were primarily non-labeled for both Fe-limited and phase 1 Fe-starved cells: 
non-labeled α-KG at 89.5 ± 0.8% and 96.9 ± 0.1% respectively, non-labeled fumarate at 99.9 ± 
0.0% and 96.9 ± 0.1 respectively, and finally, non-labeled OAA at 84.9 ± 0.3% and 99.0 ± 0.2%, 
respectively (Fig. 20, 21 and 22).  
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Long-term isotopic enrichment of intracellular enabled us to map out the metabolic network. 
We further applied a MFA approach to quantify the carbon fluxes through the series of metabolic 
reactions in the cellular network generated above. 
 
Fig. 19: Schematic representation of 13C-labeled metabolites in the TCA cycle when grown on [1,5,6-13C3]-
glucose and unlabeled benzoate. Metabolite abbreviations are the same as in Fig 1 (Kukurugya, 2017). 
 
 
34 
 
 
Fig. 20: The isotopic labeling fractions, with standard deviations, for eight intracellular metabolites in central 
carbon metabolism when grown on [1,5,6-13C3]-glucose and unlabeled benzoate under Fe-limitation at O.D600 
0.4 and 0.8. Metabolite abbreviations are the same as in Fig 1. 
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Fig. 21: The isotopic labeling fractions, with standard deviations, for eight intracellular metabolites in central 
carbon metabolism when grown on [1,5,6-13C3]-glucose and unlabeled benzoate during first phase of Fe-
starvation at O.D600 0.4 and 0.8. Metabolite abbreviations are the same as in Fig 1. 
0%
20%
40%
60%
80%
100%
O.D 0.4 O.D 0.8
Glucn
0%
20%
40%
60%
80%
100%
O.D 0.4 O.D 0.8
6PG
0%
20%
40%
60%
80%
100%
O.D 0.4 O.D 0.8
Pyruvate
0%
20%
40%
60%
80%
100%
O.D 0.4 O.D 0.8
Succinate
0%
20%
40%
60%
80%
100%
O.D 0.4 O.D 0.8
a-KG
0%
20%
40%
60%
80%
100%
O.D 0.4 O.D 0.8
Citrate
0%
20%
40%
60%
80%
100%
O.D 0.4 O.D 0.8
Aspartate (OAA)
0%
20%
40%
60%
80%
100%
O.D 0.4 O.D 0.8
Fumarate
36 
 
 
 
Fig. 22: The isotopic labeling fractions, with standard deviations, for eight intracellular metabolites in in 
central carbon metabolism when grown on [1,5,6-13C3]-glucose and unlabeled benzoate during second phase of 
Fe-starvation at O.D600 0.4 and 0.8. Metabolite abbreviations are the same as in Fig 1. 
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3.3 Siderophore Production  
As siderophores are well-known to be metabolite expensive, we obtained the siderophore 
secretion rate. P. putida KT2440 does not secrete other specialized siderophores in addition to 
PVD (Cornelis 2010). For the Fe-limited cells, we measured a PVD secretion rate of 
47.65±13.46 µmol gCDW
-1 h-1 (Fig. 23). It has been previously determined that a total of 62 moles 
of carbon was consumed from the central carbon metabolism to produce each mole of PVD 
(Sasnow et al., 2016; Wei and Aristilde, 2014; Schalk and Guillon 2013). Hence, the carbon 
equivalent secretion rate was measured to be 2.95±0.83 mmol C gCDW
-1 h-1 (Fig 5). For the Fe-
starved condition, the siderophore production rate was measured to be 4.67±0.4 mmol C gCDW
-1 
h-1 during the first phase. We note here the increase in the production of siderophores as a 
function of Fe limitation. However, in the second phase, the siderophore production decreased 
and was measured at 1.36±0.01 mmol C gCDW
-1 h-1. Interestingly, this is in accordance with cells 
grown exclusively on glucose, quantified at 1.47±0.27 mmol C gCDW
-1 h-1 (Sasnow et al., 2016) 
(Fig 5). This could be due to the diauxic trend of growth in the Fe-starved cultures leading to the 
consumption of glucose as the primary substrate. We also note that our findings were consistent 
with previous work (Joshi et al., 2014) that implied an increased siderophore production in 
Pseudomonas cells grown on aromatic substrates.  
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Fig 23: PVD secretion rates (µmolgCDW-1h-1) for P. putida KT2440 cells grown on Fe-limited and Fe-starved 
glucose:benzoate and on Fe-limited glucose (Sasnow et al, 2016) medium.  
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      3.4 Metabolic Flux Analysis 
In order to determine the relative contributions of the different metabolic reactions in the Fe-
replete and Fe-limited cells, we applied an MFA approach to quantitate the fluxes through 
various metabolic pathways. In addition to the steady-state 13C-labeling experiments with [1,5,6 
13C3]-glucose and unlabeled benzoate, our MFA was constrained using experimentally-
determined substrate consumption rates, metabolite excretion rates, siderophore secretion rate 
and biomass growth. The agreement between model-estimated and experimentally-determined 
labeling patterns confirmed the good quality of the optimization fits for modeling the carbon 
metabolism in cells grown on Fe-replete and Fe-limited conditions. The normalized reactions 
rates (ratio of metabolic reaction rates over the composite substrate uptake rate) were determined 
(Fig. 24 and Table 1). In the Fe-replete and Fe-limited model, the normalized uptake rates for 
glucose uptake (44.2 ± 1.8% and 47.8 ± 20.3 %, respectively) and benzoate uptake (55.8 ± 1.7% 
and 52.23 ± 6.1%) were consistent with the relative fraction of the experimentally-determined 
values for substrate consumption (42.1 ± 9.4% and 42.8 ± 19.3%, respectively for glucose; and 
57.9 ± 17.2% and 57.1 ± 4.0 %, respectively for benzoate) (Fig. 24 and Table 1).   
For the Fe-replete and Fe-limited models, the MFA revealed similar fractional ratio of the 
total glucose uptake rate that was subjected to oxidation to gluconate (36.8 ± 1.3 % and 37.9 ± 
2.3%, respectively). However, Fe-limited cells revealed a slight increase in the fraction of 
periplasmic glucose that was subjected to phosphorylation to G6P (11.7 ± 5.3%) when compared 
to the Fe-replete model (7.4 ± 0.5 %). Interestingly, the MFA also revealed that despite being 
under Fe-limitation, the metabolic fluxes across the ED pathway and reverse EMP pathway were 
not significantly impacted, and were in close agreement with the Fe-replete model. This was 
indicated by the similarity in the fluxes of 6-PG to pyruvate and GAP (41.8 ± 1.4 %), GAP to 
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DHAP (15.9 ± 0.6 %), DHAP and GAP to FBP (6.1 ± 1.2 %), FBP to F6P (12.1 ± 2.5%) and 
F6P to G6P (4.1 ± 0.8%) when cells were grown on the Fe-replete medium compared to cells 
grown on Fe-limited medium (43.3 ± 16.0 %, 23.3 ± 9.2 %, 7.7 ± 5.0 %, 15.1 ± 9 %, and 4.2 ± 
1.7%, correspondingly) (Fig. 24 and Table 1). However, the flux from GAP to 3-PG was 
significantly reduced in the Fe-limited (4.06 ± 0.3 %) cells when compared to Fe-replete cells 
(12.2 ± 1.1 %). The flux from 3-PG to PEP remained the same across both conditions, but the 
flux from PEP to pyruvate was also reduced in the Fe-limited cells (3.8 ± 2.1 %) when compared 
to Fe-replete cells (17.9 ± 2.9 %). This was consistent with the Fe-limited behavior of glucose-
grown cells (Sasnow et al., 2016).  
Furthermore, the investment of carbon into the PP pathway was marginally increased in the 
Fe-limited cells (4.1 ± 1.4 %) when compared to Fe-replete cells (2.1 ± 0.0 %). This could 
potentially be due to the demand of PPP metabolites towards siderophore production in the Fe-
limited cells. Under both conditions, the flux from Glucn to 2-Keto-Glucn was in close 
agreement with the flux from 2-Keto-Glucn to 6-PG, indicating a negligible excretion rate of 2-
Keto-Glucn (0.05 ± 0.0 % for Fe-replete cells and 0.06 ± 0.0% for Fe-limited cells) (Table 1). As 
reported by Kukurugya (2017), our model also revealed that 6-PG was primarily derived from 
Glucn and 2-Keto-Glucn, and only secondarily derived from G6P. This was indicated by the 
lower flux of G6P to 6-PG (9.4 ± 0.0 % for Fe-replete and 11.9 ± 5.1 % for Fe-limited cells) 
when compared to the total flux of Glucn and 2-Keto-Glucn towards 6-PG (approximately 34.7 
% for Fe-replete cells and 44.7 % for Fe-limited cells). 
In the TCA cycle, the MFA results confirmed the participation of the glyoxylate shunt 
across both conditions (57.7 ± 7.6 % in Fe-replete cells and 53.5 ± 5.2 % in Fe-limited cells). 
Notably, the flux from succinate to fumarate (127.9 ± 8.3 %), fumarate to malate (128.9 ± 8.2 
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%), and malate to OAA (104.3 ± 3.5 %) was higher in the Fe-replete cells as compared to the Fe-
limited cells (116.6 ± 5.2, 117.4 ± 4.0 %, and 90.9  ± 5.1 %, respectively) (Fig. 24). This was 
also in agreement with glucose grown Fe-limited cells (Sasnow et al., 2016).  
 
Fig 24: Metabolic flux analysis of Fe-replete Glucose:Benzoate. Abbreviations are as listed above. The MFA 
output of each metabolic reaction, the flux value, and the standard deviation of the flux value normalized to the 
Glucose:Benzoate consumption rate. The color blue and red represent the metabolic reaction rates (normalized 
to the composite uptake rate) of the Fe-replete and Fe-limited cells, respectively. Metabolites labeled green are 
involved in siderophore biosynthesis. 
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Table 1. The MFA output of each metabolic reaction, the flux value, and the standard deviation 
of the flux value normalized to the composite consumption rate. The reactions and fluxes shown 
in red are either secretions or biomass effluxes from the identified node. The values in blue 
represent the values seen in Fig. 8. 
 
Fe-Replete Fe-limited 
Reaction Flux Value 
(%) 
Standard Dev 
(%) 
Flux Value 
(%) 
Standard Dev 
(%) 
BM_AKG 10.77 0.23 10.07 0.01 
BM_E4P 3.57 0.22 3.58 0.00 
BM_OAA 14.49 0.29 13.18 0.57 
BM_PEP 7.49 0.24 7.38 0.00 
BM_PG3 8.11 0.34 8.22 0.00 
BM_PYR 16.74 0.76 15.22 1.16 
BM_R5P 2.70 0.16 2.70 1.16 
Ex_AcCoA 16.76 0.64 15.48 1.02 
Ex_DHAP 3.87 1.93 8.10 0.00 
Ex_F6P 0.00 0.00 0.00 0.00 
Ex_G6P 2.14 0.04 2.22 0.00 
Ex_Glucn 2.15 0.04 2.25 0.00 
Ex_KG2 0.05 0.00 0.06 0.00 
Ex_Mal 8.31 0.33 7.72 0.53 
Ex_S7P 4.29 1.97 6.16 7.83 
Ex_X5P 1.13 0.50 3.62 2.52 
Glucn->2KG 23.79 0.93 32.55 0.00 
2KG->6PG 23.74 0.93 32.49 0.00 
OAA->Fum 1.00 0.00 1.23 0.75 
Mal->Pyr+CO2 74.00 12.67 72.73 5.31 
G6P->6PG 9.38 0.05 11.88 5.34 
6PG->Pyr + GAP 41.84 1.37 43.40 16.26 
G6P->F6P -4.10 0.50 -4.27 2.63 
FBP->DHAP+GAP -6.06 1.25 -7.46 4.01 
GAP->PG3 12.22 1.13 4.06 0.27 
PG3->PEP 4.11 0.79 4.29 0.46 
PEP->Pyr 17.96 2.90 3.80 2.94 
DHAP->GAP -15.99 0.58 -23.25 9.29 
Glucperi->Glucn 36.82 1.28 37.94 23.06 
DHAP+GAP->FBP 6.06 1.25 7.69 5.29 
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FBP->F6P 12.12 2.51 15.15 9.30 
Cit->Glx+Succ 57.68 7.61 53.45 5.23 
Glx+AcCoA->Mal 57.68 7.61 53.45 5.23 
Benz-
>AcCoA+Succ 
55.77 1.65 52.23 6.05 
X5P+R5P-
>GAP+S7P 
2.07 0.36 3.34 0.70 
GAP+S7P-
>E4P+F6P 
-2.22 1.61 -3.65 5.96 
E4P+Xu5P-
>F6P+GAP 
-5.80 1.39 -7.23 5.96 
Ru5P->X5P 1.05 0.53 -1.11 1.57 
Ru5P->R5P 1.08 0.53 5.21 3.03 
6PG->Ru5P 2.16 0.00 4.10 1.46 
Pyr->AcCoA+CO2 101.59 11.68 91.21 12.72 
Pyr+CO2->OAA 15.46 0.20 13.50 0.00 
OAA->PEP+CO2 21.34 2.34 15.47 3.40 
OAA+AcCoA-> 
Citrate 
82.93 6.37 74.52 0.43 
Citrate->aKG 25.25 1.23 21.07 4.80 
aKG->Succ+CO2 14.48 1.00 11.00 4.80 
Succ->Fum 127.93 8.26 116.68 5.10 
Fum->Mal 128.93 8.25 117.90 4.80 
Mal->OAA 104.31 3.54 90.90 5.14 
Gluc->Glucperi 44.23 1.77 47.77 20.34 
CO2out->CO2 46.88 0.03 40.70 11.73 
Glucperi->G6P 7.42 0.51 11.66 5.31 
Glucnperi->6PG 10.88 0.39 12.18 10.26 
Benz->Benzperi 55.77 1.65 52.23 6.05 
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Table 2. The metabolic flux values from the MFA. The units for the Average value and the 
Standard deviation are (mmol gCDW
-1 h-1). 
 
Fe-replete Fe-limited 
Reaction Av. (mmol gCDW
-1 h-
1) 
Std. 
Dev. 
Av. (mmol gCDW
-1 h-1) Std. 
Dev. 
BM_AKG 0.84 0.02 1.31 0.00 
BM_E4P 0.28 0.02 0.46 0.00 
BM_OAA 1.13 0.02 1.71 0.07 
BM_PEP 0.58 0.02 0.96 0.00 
BM_PG3 0.63 0.03 1.07 0.00 
BM_PYR 1.31 0.06 1.98 0.15 
BM_R5P 0.21 0.01 0.35 0.15 
Ex_AcCoA 1.31 0.05 2.01 0.13 
Ex_DHAP 0.30 0.15 1.05 0.00 
Ex_F6P 0.00 0.00 0.00 0.00 
Ex_G6P 0.17 0.00 0.29 0.00 
Ex_Glucn 0.17 0.00 0.29 0.00 
Ex_KG2 0.00 0.00 0.01 0.00 
Ex_Mal 0.65 0.03 1.00 0.07 
Ex_S7P 0.33 0.15 0.80 1.02 
Ex_X5P 0.09 0.04 0.47 0.33 
Glucn->2KG 1.86 0.07 4.22 0.00 
2KG->6PG 1.85 0.07 4.22 0.00 
OAA->Fum 0.08 0.00 0.16 0.10 
Mal->Pyr+CO2 5.78 0.99 9.44 0.69 
G6P->6PG 0.09 0.00 1.54 0.69 
6PG->Pyr + GAP 3.27 0.11 5.63 2.11 
G6P->F6P -0.32 0.04 -0.55 0.34 
FBP->DHAP+GAP -0.47 0.10 -0.97 0.52 
GAP->PG3 0.95 0.09 0.53 0.04 
PG3->PEP 0.32 0.06 0.56 0.06 
PEP->Pyr 1.40 0.23 0.49 0.38 
DHAP->GAP -1.25 0.05 -3.02 1.21 
Glucperi->Glucn 2.87 0.10 4.92 2.99 
DHAP+GAP->FBP 0.47 0.10 1.00 0.69 
FBP->F6P 0.95 0.20 1.97 1.21 
Cit->Glx+Succ 4.50 0.59 6.94 0.68 
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Glx+AcCoA->Mal 4.50 0.59 6.93 0.68 
Benz->AcCoA+Succ 4.35 0.13 6.78 0.79 
X5P+R5P->GAP+S7P 0.16 0.03 0.43 0.09 
GAP+S7P->E4P+F6P -0.17 0.13 -0.47 0.77 
E4P+Xu5P-
>F6P+GAP 
-0.45 0.11 -0.94 0.77 
Ru5P->X5P -0.20 0.04 -0.14 0.20 
Ru5P->R5P 0.37 0.04 0.68 0.39 
6PG->Ru5P 0.17 0.00 0.53 0.19 
Pyr->AcCoA+CO2 7.93 0.91 11.84 1.65 
Pyr+CO2->OAA 1.21 0.02 1.75 0.00 
OAA->PEP+CO2 1.67 0.18 2.01 0.44 
OAA+AcCoA->Citrate 6.47 0.50 9.67 0.06 
Citrate->aKG 1.97 0.10 2.73 0.62 
aKG->Succ+CO2 1.13 0.08 1.43 0.62 
Succ->Fum 5.09 0.00 15.14 0.73 
Fum->Mal 10.06 0.64 15.30 0.63 
Mal->OAA 8.14 0.28 11.80 0.67 
Gluc->Glucperi 3.45 0.14 6.20 2.64 
CO2out->CO2 3.66 0.00 5.28 1.52 
Glucperi->G6P 0.58 0.04 1.51 0.69 
Glucnperi->6PG 0.85 0.03 1.58 1.33 
Benz->Benzperi 4.35 0.13 6.78 0.79 
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4. CONCLUDING REMARKS 
 
Here we employed a stable isotope-assisted metabolomics and MFA to unravel the consequences 
of Fe-limitation on the metabolism of mixed substrates by a model soil bacterium of 
biotechnological importance, Pseudomonas putida KT2440. It has already been established that 
this bacterium can utilize both sugars and aromatic substrates simultaneously. The focus of this 
study was to elucidate the Fe-dependent cellular reprogramming of mixed-substrate metabolism.  
Our work revealed several findings that contribute to a better understanding of nutrient-
dependent carbon metabolism. First, we report that the Fe-limitation did not affect biomass 
growth of the cells, but instead, caused an overall increase in substrate consumption coupled with 
secretion of the pyoverdine siderophore. Second, with the increase in the extent of Fe-limitation, 
we found an increase in the preferential intake of the aromatic substrate. In the condition with the 
lowest bioavailable Fe, the growth was divided across two phases, wherein the aromatic 
substrate was consumed in the first phase, followed by the sugar in the second phase. This 
validated our hypothesis that the increase in the preferential intake of the aromatic substrate was 
due to its favorability in the production of siderophores. Third, it was evident that the glucose-
derived carbons mainly populated the ED and reverse EMP pathways whereas benzoate-derived 
carbons dominated the TCA and glyoxylate cycles across all conditions. However, under Fe-
limitation and Fe-starvation, we found that benzoate was minimally incorporated into G6P, 
DHAP, FBP and F6P. 
For the further directions of this project, additional MFA models for each phase of the 
diauxic growth in the Fe-starvation condition would further elucidate the reprogramming of 
mixed substrate metabolism in response to very low Fe availability. Additionally, kinetic flux 
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experiments for the mixed substrates under Fe-limitation and Fe-starvation could potentially 
shed light upon the in vivo changes in metabolic enzyme activity. Finally, using proteomic 
analysis for the Fe-replete and Fe-limited conditions to connect the elucidated changes in carbon 
fluxes to specific enzymatic regulation could aid in the determination of the level of regulation in 
P.putida KT2440 under Fe-limitation. 
It is widely known that P. putida KT2440 is ubiquitous in soil environments. As the 
bioavailability of Fe in the environment is very low, and glucose and aromatics are present as 
either naturally occurring compounds or contaminants, this study poses a significant contribution 
towards a comprehensive understanding of the effects of Fe-limitation on mixed substrate 
metabolism in the environment. Furthermore, P. putida is extensively used for its biocontrol and 
bioremediation properties. The findings demonstrated in this study and the collective efforts 
mentioned above can in turn support the development of novel biotechnological applications in 
industrial bioengineering and bioremediation. 
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Appendix 
 
 
 
 
Figure S1. The isotopic labeling fractions, with standard deviations, for nine intracellular metabolites in the ED 
and EMP pathways when grown on [U-13C6]-glucose and unlabeled benzoate under Fe-limitation. Metabolite 
abbreviations are the same as in Fig 1. 
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Figure S2. The isotopic labeling fractions, with standard deviations, for nine intracellular metabolites in the 
TCA cycle and PP pathway when grown on [U-13C6]-glucose and unlabeled benzoate under Fe-limitation. 
Metabolite abbreviations are the same as in Fig 1. 
 
 
 
 
 
 
 
 
 
 
0%
20%
40%
60%
80%
100%
O.D 0.4 O.D 0.8
Pyruvate
0%
20%
40%
60%
80%
100%
O.D 0.4 O.D 0.8
Aspartate (OAA)
0%
20%
40%
60%
80%
100%
O.D 0.4 O.D 0.8
Fumarate
0%
20%
40%
60%
80%
100%
O.D 0.4 O.D 0.8
Succinate
0%
20%
40%
60%
80%
100%
O.D 0.4 O.D 0.8
a-KG
0%
20%
40%
60%
80%
100%
O.D 0.4 O.D 0.8
Citrate
0%
20%
40%
60%
80%
100%
O.D 0.4 O.D 0.8
X5P
0%
20%
40%
60%
80%
100%
O.D 0.4 O.D 0.8
S7P
0%
20%
40%
60%
80%
100%
O.D 0.4 O.D 0.8
R5P
53 
 
 
 
 
 
Figure S3. The isotopic labeling fractions, with standard deviations, for nine intracellular metabolites in the ED 
and EMP pathways when grown on [U-13C6]-glucose and unlabeled benzoate under Fe-starvation. Metabolite 
abbreviations are the same as in Fig 1. 
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Figure S4. The isotopic labeling fractions, with standard deviations, for intracellular metabolites in the TCA 
cycle and PP pathway when grown on [U-13C6]-glucose and unlabeled benzoate under Fe-starvation. 
Metabolite abbreviations are the same as in Fig 1. 
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